(Q36163778)

12 August 2017

1 reference

title

The Goldman Consensus statement on depression in multiple sclerosis (English)

1 reference

12 August 2017

0 references

Goldman Consensus Group

series ordinal

1

1 reference

12 August 2017

publication date

1 June 2005

1 reference

Multiple Sclerosis Journal

12 August 2017

published in

1 reference

12 August 2017

volume

11

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

328-337

1 reference

Affective disorders in multiple sclerosis. Review and recommendations for clinical research

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis. An epidemiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Depression before and after diagnosis of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Psychiatric side effects of steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Interferon beta1a and depression in secondary progressive MS: data from the SPECTRIMS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Major depression and quality of life in individuals with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Correlates of quality of life among persons with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Depression in multiple sclerosis as a function of length and severity of illness, age, remissions, and perceived social support

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Psychological stress and the subsequent appearance of new brain MRI lesions in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Psychological stress as risk factor for exacerbations in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Nonspecific stress prevents relapses of experimental allergic encephalomyelitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Suicide and multiple sclerosis: an epidemiological investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Risk factors for suicide in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Multiple sclerosis, depression, and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

An examination of suicidal intent in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Adrenal size is increased in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Disease activity and emotional state in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Involvement of the limbic system in multiple sclerosis patients with depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Minimal neuropsychological assessment of MS patients: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Relationship between coping, cognitive dysfunction and depression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Depression, coping and level of neurological impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

A Descriptive Analysis of Minor Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

Antidepressant pharmacotherapy of depression associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1162OA

10.1191/1352458505MS1162OA

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference